Free Trial

Legend Biotech (LEGN) SEC Filings & 10K Form

Legend Biotech logo
$30.68 +0.44 (+1.44%)
As of 02:54 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Legend Biotech SEC Filings

DateFilerForm TypeView
03/25/2025
2:47 PM
Legend Biotech (Subject)
Yeung Jessie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2025
2:41 PM
Huang Ying (Reporting)
Legend Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2025
11:15 AM
Legend Biotech (Subject)
Sanders Corazon D. (0001796536) (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2025
10:42 AM
Legend Biotech (Subject)
Macomber Lori (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2025
6:00 AM
Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2025
8:44 AM
Legend Biotech (Subject)
Form SCHEDULE 13G/A
01/22/2025
6:30 AM
Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/14/2025
3:01 PM
Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/10/2025
2:14 PM
Legend Biotech (Subject)
Macomber Lori (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/26/2024
8:48 AM
Legend Biotech (Subject)
Macomber Lori (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/26/2024
8:59 AM
Huang Ying (Reporting)
Legend Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/23/2024
3:01 PM
Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/09/2024
6:35 PM
Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/02/2024
2:08 PM
Heyman Tomas J. (Reporting)
Legend Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
7:46 AM
Legend Biotech (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/12/2024
6:03 AM
Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/05/2024
8:10 AM
Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/22/2024
7:00 AM
Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
6:30 AM
Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
3:35 PM
Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2024
2:30 PM
Huang Ying (Reporting)
Legend Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2024
3:43 PM
Legend Biotech (Subject)
Macomber Lori (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2024
9:46 AM
Legend Biotech (Subject)
Yau Wai Man Philip (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2024
7:01 AM
Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/27/2024
6:30 AM
Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/09/2024
6:01 AM
Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/26/2024
6:00 AM
Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/17/2024
6:30 AM
Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/02/2024
7:00 AM
Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2024
3:32 PM
Legend Biotech (Subject)
Macomber Lori (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/25/2024
3:25 PM
Huang Ying (Reporting)
Legend Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2024
4:00 PM
Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/13/2024
6:01 AM
Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/22/2024
12:06 PM
Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/16/2024
6:29 AM
Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
6:03 AM
Legend Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:LEGN) was last updated on 4/8/2025 by MarketBeat.com Staff
From Our Partners